333.10MMarket Cap70.04P/E (TTM)
19.574High18.400Low189.91KVolume19.020Open19.010Pre Close3.57MTurnover1.27%Turnover RatioLossP/E (Static)17.62MShares29.82052wk High-22.76P/B282.56MFloat Cap7.48452wk Low--Dividend TTM14.94MShs Float1147.499Historical High--Div YieldTTM6.18%Amplitude6.400Historical Low18.810Avg Price1Lot Size
Rigel Pharmaceuticals Stock Forum
whoa! some Dip
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDS
Rigel Pharmaceuticals (Nasdaq: RIGL) announced that the FDA has granted Fast Track designation to R289 for treating patients with previously-treated transfusion dependent lower-risk myelodysplastic syndrome (LR-MDS). R289, a dual inhibitor of IRAK1 and IRAK4, is currently being evaluated in a Phase 1b study. The Fast Track designation may provide benefits including more freque...
Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk Mds
Let's break 30.+
27.+
Let's Get 30.+
No comment yet